BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Nurix Therapeutics to Participate in Upcoming November 2025 Investor Conferences

  October 31, 2025

   · 

  2 min read
• Press Releases

  Syndax Announces Participation in November 2025 Investor Conferences

  October 31, 2025

   · 

  1 min read
• Press Releases

  Phathom Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

  October 31, 2025

   · 

  15 min read
• Press Releases

  Option Care Health Announces Financial Results For the Third Quarter Ended September 30, 2025

  October 31, 2025

   · 

  11 min read
• Press Releases

  Cartesian Therapeutics Announces Carsten Brunn, Ph.D., Named as Chairman of the Company’s Board of Directors

  October 31, 2025

   · 

  5 min read
• Press Releases

  Gain Therapeutics to Present at Neuroscience 2025

  October 31, 2025

   · 

  5 min read
• Press Releases

  Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting

  October 31, 2025

   · 

  5 min read
• Press Releases

  Seres Therapeutics to Announce Third Quarter 2025 Financial Results and Business Updates on November 5, 2025

  October 31, 2025

   · 

  2 min read
• Press Releases

  Forward Therapeutics Announces First Participants Dosed in Phase 1 Healthy Volunteer Study of FT2109, a Next-Generation TNF Signaling Inhibitor

  October 31, 2025

   · 

  2 min read
• Press Releases

  Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results

  October 31, 2025

   · 

  22 min read